Table 2. Incidence of acute dermatolymphangioadenitis (ADLA), in episodes per person-year, among 175 patients with lymphedema in Leogane, Haiti, by demographic, disease-related, and treatment-related factors, univariate analysis.

Characteristic	Value or status	N	ADLA incidence (range)	P
Gender	Male	30	.83 (0–5.6)	.4946
	Female	145	.74 (0–2.9)
Age (years)	≥40	80	.77 (0–5.6)	.8093
	<40	90	.75 (0–3.2)
Literacy	Illiterate	88	1.01 (0–5.6)	<.0001
	Literate	87	.47 (0–2.5)
Bilateral lymphedema (>stage 2 bilaterally)	Yes	55	.87 (0–3.0)	.0740
	No	120	.69 (0–5.6)
Lymphedema duration (years)	≥10	78	.72 (0–3.8)	.6275
	<10	97	.77 (0–5.6)
Median leg volume (n = 350 legs)	≥2000 mL	125	1.35	<.0001
	1700–1999 mL	117	.52	.13
	<1700 mL	108	.33	Referent
ADLA frequency during the year before entering the study, based on 12-month recall (episodes per year)	>2.0	84	.94 (0–5.6)	.0004
	0.1–2.0	55	.59 (0–3.8)	.2416
	0	36	.44 (0–2.9)	Referent
Ever used compression bandages or garments during study	Yes	122	.88	<.0001
	No	53	.43	Referent
Lymphedema stage, by leg (n = 350 legs)	4	13	1.08	<.0001
	3	85	1.52	<.0001
	2	129	.76	<.0001
	1	38	.37	.0015
	0	85	0	Referent